Sumitovant Biopharma Ltd.

A previous regulatory setback in the US for Kissei Pharmaceutical Co., Ltd ’s female health product linzagolix has not discouraged the Japanese firm from continued development of the oral gonadotropi

Roivant Sciences Ltd. said it is poised to take on AbbVie Inc. ’s Humira in non-infectious uveitis, a leading cause of blindness, after reporting Phase II data showing that brepocitinib met its prim

Sumitomo Pharma Co., Ltd. has decided to cut another 400 employees at its US subsidiary Sumitomo Pharma America, Inc. (SPMA) after already reducing headcount there by 500 in an earlier reorganization

ImmunoGen, Inc. and Protagonist Therapeutics, Inc. accomplished in early April what has become increasingly difficult for public biotechnology companies to do when they accessed significant amounts